Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
纳武利尤单抗联合阿贝西利加内分泌治疗治疗 HR 阳性 HER2 阴性转移性乳腺癌患者的疗效、安全性和生物标志物分析:一项 II 期研究(WJOG11418B NEWFLAME 试验)
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007126
Masuda, Jun; Sakai, Hitomi; Tsurutani, Junji; Tanabe, Yuko; Masuda, Norikazu; Iwasa, Tsutomu; Takahashi, Masato; Futamura, Manabu; Matsumoto, Koji; Aogi, Kenjiro; Iwata, Hiroji; Hosonaga, Mari; Mukohara, Toru; Yoshimura, Kiyoshi; Imamura, Chiyo K; Miura, Sakiko; Yamochi, Toshiko; Kawabata, Hidetaka; Yasojima, Hiroyuki; Tomioka, Nobumoto; Yoshimura, Kenichi; Takano, Toshimi